PATENT CLAIM ANALYSIS

Application Number: 15912904
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "275100"]

Abstract:
Compositions and methods for the treatment of allergic disease include treating a subject in need thereof with a dosage of an allergen, wherein the allergen is administered to the subject's oral vestibular space. In a preferred embodiment, the allergen is administered at night, thereby exploiting circadian rhythms in the subject's immune response and enhancing the effectiveness of the treatment.

Claim (Index 7):
A method for treating allergic disease, the method comprising:\n providing an allergen to a person; and instructing the person to self-administer the allergen at night, the instructing including defining a treatment period having a first phase and a second phase, wherein in the first phase the person self-administers the allergen to its sublingual space, and wherein in the second phase the person self-administers the allergen to its oral vestibular space.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.53488
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13695169', '15022249', '14897575', '12988513', '13946664']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7079979255648401
- 35 USC 102 Novelty (BERT): 0.4989458116894371
- Combined Prediction Score: 0.6870927141772999
- Mean Citation Score: 212.700746
- Max Citation Score: 250.15022
- Similarity Product: 182.48264610152123

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test